Pasithea Therapeutics Corp (KTTA)
6.40
-0.15
(-2.29%)
USD |
NASDAQ |
May 24, 16:00
6.41
+0.01
(+0.16%)
After-Hours: 20:00
Pasithea Therapeutics Total Liabilities (Quarterly): 2.525M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 2.525M |
| December 31, 2023 | 2.718M |
| September 30, 2023 | 2.284M |
| June 30, 2023 | 2.559M |
| March 31, 2023 | 2.910M |
| December 31, 2022 | 2.682M |
| September 30, 2022 | 2.820M |
| Date | Value |
|---|---|
| June 30, 2022 | 1.554M |
| March 31, 2022 | 1.101M |
| December 31, 2021 | 1.900M |
| September 30, 2021 | 4.567M |
| June 30, 2021 | 0.4547M |
| March 31, 2021 | 0.2395M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.2395M
Minimum
Mar 2021
4.567M
Maximum
Sep 2021
2.178M
Average
2.525M
Median
Mar 2024
Total Liabilities (Quarterly) Benchmarks
| CEL-SCI Corp | 15.74M |
| AIM ImmunoTech Inc | 11.36M |
| IGC Pharma Inc | 2.206M |
| NovaBay Pharmaceuticals Inc | 5.197M |
| Protalix BioTherapeutics Inc | 60.04M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 22.41M |
| Shareholders Equity (Quarterly) | 19.88M |